Ozurdex

ApprovedSmall molecule

AbbVie

Ozurdex is one of 165 small molecule programs targeting Epiretinal membrane. It is currently in Approved.

Indications

Total Trials

Active Trials

164

Competitors

Pipeline

Status by Indication[3][1]

Indication

Epiretinal MembraneActive, not recruiting

Macular DegenerationActive, not recruiting

FibrosisActive, not recruiting

Uveal MelanomaActive, not recruiting

Retinal Vein OcclusionActive, not recruiting

Diabetic Macular EdemaActive, not recruiting

Epiretinal MembranePreclinical

Active, not recruiting

Macular DegenerationPhase 2

Active, not recruiting

FibrosisPreclinical

Active, not recruiting

Uveal MelanomaPhase 2

Active, not recruiting

Retinal Vein OcclusionApproved

Active, not recruiting

Diabetic Macular EdemaApproved

Active, not recruiting

Competition

Competitive Landscape

180 competitors in Diabetic Macular Edema

#DrugCompanyPhaseTrials

Eylea

Regeneron

Phase 3

54 2

Lucentis

Roche

Phase 3

59 3

Avastin

BBio-Thera Solutions

Phase 3

23 4

Beovu

Novartis

Phase 3

6 5

Kenalog

BBausch Health Americas, Inc.

Phase 3

14 6

Ozurdex

AbbVie

Approved

6 7

Synalar

EEurofarma Laboratorios S.A.

Phase 3

4 8

Lucentis

Novartis

Phase 3

8 9

Luye Pharma Conbercept

CChengdu Kanghong Biotech Co., Ltd.

Phase 3

3 10

Glucophage

EMD Serono

Phase 3

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Diabetic Macular Edema6 trials

Combination OZURDEX® & LUCENTIS® vs. OZURDEX® Monotherapy in Incomplete-Responders With Diabetic Macular Edema

Terminated·NNorth Toronto Eye Care Laser and Eye Specialists·Phase 4·NCT02684084·5 enrolled

Anti-Vascular Endothelial Growth Factor (Anti-VEGF) Alone Versus Ozurdex Given Every 3 Months for Treatment of Persistent Diabetic Macular Edema

Completed·—·Phase 4·NCT02036424·45 enrolled

Ozurdex for Diabetic Macular Edema Treated With Pars Plana vitrEctomy and Membrane RemovAl (OPERA Study)

Completed·TThe Cleveland Clinic·Phase 4·NCT01613716·30 enrolled

Show 3 more trials

Combination OZURDEX® & EyLea® vs. OZURDEX® Monotherapy in IncompLete-Responders wIth Diabetic Macular Edema

Withdrawn·PPradeepa Yoganathan·Phase 2·NCT03629210

Retrospective Trial on the Efficacy and Safety of Intravitreal Ozurdex in Patients With Diabetic Macular Edema.

Completed·AAssociation for Innovation and Biomedical Research on Light and Image··NCT02121197·321 enrolled

Steroid vs. Anti-vascular Endothelial Growth Factor for Diabetic Macular Edema Prior to Phacoemulsification

Completed·BBay Area Retina Associates·Phase 4·NCT03832179·16 enrolled

Retinal Vein Occlusion4 trials

Ozurdex Versus Ranibizumab Versus Combination for Central Retinal Vein Occlusion

Unknown status·VValley Retina Institute·Phase 4·NCT01827722·45 enrolled

Efficacy of an Intravitreal DEX Implant in Retinal Vein Occlusion Following Treatment With Anti-VEGF Injections.

Completed·RRetina Macula Institute·Phase 3·NCT01449682·10 enrolled

Comparison of Initial Ozurdex (Dexamethasone Implant) to Avastin (Bevacizumab) for Treatment of Macular Edema Caused by Central Retinal Vein Occlusion (CRVO)

Completed·LLong Island Vitreoretinal Consultants·N/A·NCT01231633·27 enrolled

Show 1 more trial

Evaluation of OZURDEX® in Patients With Macular Edema Secondary to Retinal Vein Occlusion in China

Completed· AbbVie logo

AbbVie·Phase 4·NCT03908307·150 enrolled

Fibrosis1 trial

Pro-permeability and Pro-fibrosis Factors in the Aqueous of Patients With Retinal Diseases

Terminated·JJohns Hopkins University··NCT02688309·44 enrolled

Epiretinal membrane1 trial

A Pilot Study of the Effectiveness of Intra-operative Ozurdex® in Vitrectomy Surgery for Epiretinal Membranes

Unknown status·SSunnybrook Health Sciences Centre·N/A·NCT01701518·15 enrolled

Macular Degeneration1 trial

OZURDEX in Age Related Macular Degeneration as Adjunct to Ranibizumab

Completed·MMcMaster University·Phase 2·NCT01243086·10 enrolled

8 more indications

Dexamethasone1 trial

Dexamethasone-Implant for the Treatment of Macula Edema Due to Irvine Gass Syndrome

Completed·LLudwig-Maximilians - University of Munich··NCT01945892·23 enrolled

Randomized Controlled Trial1 trial

Compare the Efficacy of VItrectomy Combined With DExamethasone Implant Versus With Aflibercept in DME Patients Diagnosed by Intraoperative OCT (the VIDEO Study): Study Protocol for a Randomized Controlled Trial

Unknown status·TTianjin Medical University Eye Hospital·Phase 4·NCT05990829·64 enrolled

Uveal Melanoma1 trial

Dexamethasone Intravitreal Implant for Treatment of Macular Edema After Plaque Radiotherapy of Uveal Melanoma

Terminated·AArman Mashayekhi·Phase 2·NCT01471054·6 enrolled

Trial1 trial

One Year Trial Evaluating Safety of Ozurdex With Eylea

Completed·TTexas Retina Associates·Phase 4·NCT03984110·50 enrolled

Monotherapy1 trial

Ozurdex Monotherapy Trial

Withdrawn·OOttawa Hospital Research Institute·Phase 4·NCT05101928

Treatment Failure1 trial

Ozurdex Implant for Macular Edema After Treatment Failure With Anti-VEGF

Terminated·RRetina Research Institute, LLC·N/A·NCT01946399·10 enrolled

Diabetic Macular Oedema1 trial

Trial of Switching Between Intravitreal Bevacizumab (Avastin®)& Intravitreal Dexamethasone (Ozurdex™) for Persistent Diabetic Macular Oedema

Completed·UUniversity of Sydney·Phase 2·NCT01787669·19 enrolled

Patient Preference1 trial

Patient Preferences on Same-day Bilateral Intravitreal Dexamethasone Injections

Recruiting·RRigshospitalet, Denmark··NCT06894017·200 enrolled

Sources

References

[1]
ClinicalTrials.gov — 21 trial records for Ozurdex. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Ozurdex compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Ozurdex. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — AbbVie company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Approved[1]
Company: AbbVie

Ozurdex

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Diabetic Macular Edema6 trials

Retinal Vein Occlusion4 trials

Fibrosis1 trial

Epiretinal membrane1 trial

Macular Degeneration1 trial

Dexamethasone1 trial

Randomized Controlled Trial1 trial

Uveal Melanoma1 trial

Trial1 trial

Monotherapy1 trial

Treatment Failure1 trial

Diabetic Macular Oedema1 trial

Patient Preference1 trial

References

Drug Info

Quick Facts

Related News